In nAg.Bhlhe40HiCd8, the top defining marker of this cluster was Bhlhe40 (Figures 3G and S8), which we previously demonstrated was upregulated in tumor-specific T cells and required for CD4 and/or CD8 T cell effector function and response to ICT21. This evidence concerns the gene CD8A and neoplasm.